Reviparin sodium
Pharmaceutical drug
From Wikipedia, the free encyclopedia
Reviparin is an antithrombotic and belongs to the group of low molecular weight heparins (LMWH).
| |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.110.590 |
  (what is this?) (verify) | |
Medical uses
- Prevention of blood clots
- Prophylaxis of perioperative thromboembolism[1][2]
- Treatment of DVT with or without pulmonary embolism (PE)[3]
- Prophylaxis of acute thrombotic events after percutaneous transluminal coronary angioplasty (PTCA)[4][5]
Chemistry
Reviparin is a low molecular weight heparin obtained by nitrous acid depolymerization of heparin extracted from porcine intestinal mucosa. Its structure is characterized, for the most part, by a group of 2-O-sulfo-α-lidopyranosuronic acid. The average molecular weight is about 3900 daltons.
